The price just collapsed — that’s why everyone’s asking
Full-body MRI screening used to be a $1,500–$2,500 concierge product. Then Function Health acquired Ezra and cut the price to $499, with an AI-accelerated scan that takes about 22 minutes. Suddenly the “scan everything, just in case” pitch is priced like a nice dinner for four, and patients have started asking me whether they should book one.
It’s a fair question with a genuinely two-sided answer. Here’s the honest version.
What a screening full-body MRI actually is
An MRI survey of the body — typically head through pelvis — looking for structural abnormalities: masses, lesions, aneurysms, cysts, and other things that shouldn’t be there. No radiation (unlike CT), no contrast in most screening protocols, no needles. The modern versions use AI to speed acquisition and flag findings for the reviewing radiologist.
What it is not: a cancer-rule-out. MRI sees structure, not biology. Small tumors, flat lesions, blood cancers, and many early-stage disease processes don’t show up. Like every screening tool in this space, it catches some things brilliantly and misses others entirely.
The genuine upside
Real things get found. Screening MRIs do catch early kidney tumors, brain aneurysms, and other significant findings in people who felt fine — cases where the scan plausibly changed the person’s life. Companies in this space report clinically significant findings in a meaningful minority of scans, and while those figures come from the companies themselves, the case reports are real.
For a person with means, anxiety-tolerance, and a specific reason — a strong family history of kidney or brain pathology, say, or a cancer-survivor’s vigilance — a periodic structural survey isn’t irrational. And at $499, the cost barrier that used to make this a plainly elite product is mostly gone.
The downside the ads don’t mention: incidentalomas
Scan enough healthy people head-to-pelvis and you will find things. Lots of things. Most of them meaningless.
They’re called incidentalomas — incidental findings of no consequence: benign cysts, harmless nodules, anatomical quirks. The problem is you often can’t know they’re harmless from one image. So the finding triggers follow-up: repeat imaging in six months, maybe contrast studies, sometimes biopsies. Each step carries cost, anxiety, and occasionally real harm from procedures chasing something that was never going to hurt you.
This is the central trade of whole-body screening in low-risk people: a small chance of a life-changing catch, purchased with a much larger chance of a worry-generating nothing. Neither side of that trade is imaginary. Which side dominates depends heavily on your prior risk — which is why blanket “everyone should scan” and blanket “screening scans are a scam” are both wrong.
Worth knowing: major radiology societies do not currently recommend whole-body MRI screening for average-risk adults — while acknowledging legitimate use in defined high-risk groups. That’s roughly where the evidence honestly sits.
A useful way to decide
Questions I’d actually ask before spending the $499:
- Do I have a specific elevated risk (family history, genetic syndrome, prior cancer) that a structural survey addresses? If yes, this conversation belongs with your physician anyway — and the case strengthens considerably.
- Have I done the boring, proven screenings first? If you’re overdue for a colonoscopy, that’s a better $0–$500 than any MRI. Guideline screening outperforms novelty screening for the cancers it covers.
- How will I handle an ambiguous finding? If a “6mm indeterminate lesion, recommend follow-up in 6 months” line would own your mind for half a year, price that in. If you can hold uncertainty calmly, the calculus is friendlier.
- Is my foundation actually managed? Blood pressure, metabolic labs, sleep, fitness — the unglamorous drivers of most premature death are cheaper to measure and far more actionable than a structural survey.
Where this fits in a real health strategy
My take as a clinician who reviews these decisions with patients: a full-body MRI is a tier-three tool. Tier one is the proven, guideline stuff — blood pressure, labs, age-appropriate cancer screening. Tier two is deeper functional assessment — metabolic patterns, inflammation, hormones, the things that predict how you’ll feel and age. Tier three is the wide-net structural survey for people who’ve done tiers one and two, have specific risk or specific peace-of-mind value, and go in understanding the incidentaloma trade.
Done in that order, the scan is a reasonable luxury. Done instead of tiers one and two — which is how it’s often marketed — it’s expensive reassurance pointed at the wrong risks.
Tier one and two are cheaper and more actionable than most people expect. If you’re starting there, the consumer blood panels compared is the practical entry point, and how to read your blood test results covers what to do with what comes back. My Function Health review goes deeper on the specific service that bundles this MRI.
Frequently asked questions
Are full-body MRI scans worth it?
For average-risk adults, evidence doesn’t support routine use — the incidental-finding burden is real. For people with specific elevated risk, or who’ve completed proven screening and accept the trade-offs, a periodic scan can be a defensible addition.
What does a full-body MRI detect?
Structural findings: masses, cysts, aneurysms, organ abnormalities. It does not reliably catch small or early-stage cancers, blood cancers, or non-structural disease — a clean scan is not a clean bill of health.
How much does one cost in 2026?
Function/Ezra’s AI-accelerated scan is $499; other providers (Prenuvo and similar) typically run $999–$2,500 depending on protocol.
Is the radiation a concern?
No — MRI uses magnetic fields, not ionizing radiation. That’s a genuine advantage over CT-based screening.
What happens if they find something?
Findings go to physician follow-up — often repeat or contrast imaging, sometimes biopsy. Most findings turn out benign; plan for the possibility of a months-long “watch and re-scan” process before you book.
The takeaway
The $499 full-body MRI is neither a scam nor a must-have. It’s a wide, shallow structural net with a real but modest catch rate and a very real false-alarm economy. Do the proven screening first, get your labs actually interpreted, and if you then still want the survey — go in with your eyes open about what a “finding” will mean.
Want help sequencing what’s actually worth testing for your situation? Book a consultation in Tustin or virtually.
Author: Dr. Brandon Bright, DAOM, LAc — Tustin, Orange County. Educational content; not medical advice. A DAOM/LAc does not order MRI screening; imaging decisions and follow-up of findings belong with your physician. Product details and pricing as of August 2026.